giiant pharma inc. is a Montreal-based biotech company, founded by former Merck Frosst scientists, with the aim of developing orally-administered, gut-restricted anti-inflammatory agent for the treatment of IBD.
Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in...
giiant pharma inc. is a Montreal-based biotech company, founded by former Merck Frosst scientists, with the aim of developing orally-administered, gut-restricted anti-inflammatory agent for the treatment of IBD.
Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.